Oliveto Joseph

President and CEO, DirectorMilestone Pharmaceuticals Inc. (MIST) · full profile →Form 4 · filed Jan 28, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$375K
Net Open-Market Flow
-$375K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 26, 2026Sell(S)35K$1.93$67K483K
Jan 26, 2026Option exercise(M)67K517K
Dec 15, 2025Sell(S)133K$2.32$309K451K
Dec 12, 2025Grant(A)280K584K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 26, 2026Option exercise(M)67K$0200K
Dec 12, 2025Grant(A)280K$0280K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437782-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly: